Characterization of Epitheloid Cells from Human Omentum: Comparison with Endothelial Cells from Umbilical Veins

Summary Capillary cells represent 95% of the vascular bed, and cells from large and micro-vessels do not express identical functions. In order to study the hormonal regulation of plasminogen activator inhibitor 1 (PAI-1) secretion by human capillary cells we used epithelial cells from omental tissue (HOTMEC). As their endothelial origin is subject to controversy, we attempted to determine their characteristics by comparing them to human umbilical vein endothelial cells (HUVEC). Morphological and biological criteria were studied. By phase contrast microscopy HOTMEC elicited a cobblestone pattern similar to HUVEC. Weibel-Palade bodies were not found in the cytoplasm with electron microscopy. Fluorescence microscopy studies indicated that HOTMEC took up acetylated-LDL more intensely than HUVEC, and showed no staining for von Willebrand factor. The phenotype of HOTMEC was studied by flow cytometry using monoclonal antibodies (mo Ab) directed against epitopes either specific for endothelial cells or for mesothelial cells. We showed that in our preparations only 10% of cells reacted with mo Ab specific for endothelial cells. About 60% of the HOTMEC were labelled with an antibody directed against mesothelial cells. HOTMEC expressed fibrinolytic factors. Tissue plasminogen activator (t-PA) levels in HOTMEC conditioned medium were 50 fold higher than those of HUVEC, and the PAI-1 secretions were identical in both cell types. Insulin which is known to increase PAI-1 synthesis by hepatocytes did not enhance the PAI-1 level either in HOTMEC or in HUVEC conditioned media. Our results suggested that morphological and functional methods did not allow discrimination between the cell types present in the omentum tissue. They also showed that the population obtained from the omental tissue by collagenase digestion is heterogeneous, with few cells expressing endothelial markers.

[1]  H. Dockrell.  Leucocyte Typing IV. White Cell Differentiation Antigens , 1991 .

[2]  T. Kooistra,et al.  Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. , 1990, Blood.

[3]  A. Bikfalvi,et al.  Thrombin mitogenic responses and protein phosphorylation are different in cultured human endothelial cells derived from large and microvessels. , 1989, Experimental cell research.

[4]  P. Bosma,et al.  Plasminogen Activator Inhibitor 1: Biosynthesis and mRNA Level Are Increased by Insulin in Cultured Human Hepatocytes , 1989, Thrombosis and Haemostasis.

[5]  P. Vague,et al.  Increased Plasminogen Activator Inhibitor Activity in Non Insulin Dependent Diabetic Patients – Relationship with Plasma Insulin , 1989, Thrombosis and Haemostasis.

[6]  M. Alessi,et al.  Plasma Plasminogen Activator Inhibitor‐1 in Angina Pectoris: Influence of Plasma Insulin and Acute‐phase Response , 1989, Arteriosclerosis.

[7]  W. Buurman,et al.  Induction of an activation antigen on human endothelial cells in vitro , 1989, European journal of immunology.

[8]  T. Kooistra,et al.  Insulin Stimulates the Synthesis of Plasminogen Activator Inhibitor 1 by the Human Hepatocellular Cell Line Hep G2 , 1988, Thrombosis and Haemostasis.

[9]  L. Kolodié,et al.  Different molecular weight forms of tissue-type plasminogen activator in ascitic fluid from patients with liver cirrhosis , 1988 .

[10]  M. Gerritsen,et al.  Glucose starvation is required for insulin stimulation of glucose uptake and metabolism in cultured microvascular endothelial cells. , 1988, Microvascular research.

[11]  W. Franke,et al.  Cytokeratins in certain endothelial and smooth muscle cells of two taxonomically distant vertebrate species, Xenopus laevis and man. , 1987, Differentiation; research in biological diversity.

[12]  A. L. Goodman,et al.  Heterogeneity of Rabbit Aortic Endothelial Cells in Primary Culture 1 , 1987, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[13]  K. Preissner,et al.  Differences in coagulant and fibrinolytic activities of cultured human endothelial cells derived from omental tissue microvessels and umbilical veins. , 1987, Blood.

[14]  V. Babaev,et al.  Primary culture of endothelial cells from atherosclerotic human aorta. Part 1. Identification, morphological and ultrastructural characteristics of two endothelial cell subpopulations. , 1986, Atherosclerosis.

[15]  J. Paramo,et al.  Postoperative Changes in the Plasmatic Levels of Tissue-Type Plasminogen Activator and Its Fast-Acting Inhibitor - Relationship to Deep Vein Thrombosis and Influence of Prophylaxis , 1985, Thrombosis and Haemostasis.

[16]  V. V. van Hinsbergh,et al.  High-affinity uptake and degradation of acetylated low density lipoprotein by confluent human vascular endothelial cells. , 1985, Atherosclerosis.

[17]  T. Kooistra,et al.  Inhibition of plasminogen activators by conditioned medium of human hepatocytes and hepatoma cell line Hep G2. , 1985, The Journal of laboratory and clinical medicine.

[18]  D. Lawrence,et al.  Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells. , 1984, The Journal of biological chemistry.

[19]  B. Zetter,et al.  Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein , 1984, The Journal of cell biology.

[20]  S. Thorsen,et al.  Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex. , 1984, Biochimica et biophysica acta.

[21]  D. Loskutoff,et al.  Detection and partial characterization of an inhibitor of plasminogen activator in human platelets. , 1984, The Journal of clinical investigation.

[22]  J. Verheijen,et al.  Evidence for the Occurrence of a Fast-Acting Inhibitor for Tissue-Type Plasminogen Activator in Human Plasma , 1984, Thrombosis and Haemostasis.

[23]  P. Wallén,et al.  An Enzyme Linked Immunosorbent Assay for Determination of Tissue Plasminogen Activator Applied to Patients with Thromboembolic Disease , 1983, Thrombosis and Haemostasis.

[24]  S. Buchwald,et al.  Differential responsiveness to insulin of endothelial and support cells from micro- and macrovessels. , 1983, The Journal of clinical investigation.

[25]  R. S. Bar,et al.  INTERACTIONS OF INSULIN AND INSULIN‐LIKE GROWTH FACTORS (IGF) WITH ENDOTHELIAL CELLS * , 1982, Annals of the New York Academy of Sciences.

[26]  J. Weinstein,et al.  Acetoacetylated Lipoproteins Used to Distinguish Fibroblasts from Macrophages In Vitro by Fluorescence Microscopy , 1981, Arteriosclerosis.

[27]  R. Mahley,et al.  Altered metabolism (in vivo and in vitro) of plasma lipoproteins after selective chemical modification of lysine residues of the apoproteins. , 1979, The Journal of clinical investigation.

[28]  M. Brown,et al.  Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. E. West,et al.  Separation of plasma lipoproteins by density-gradient ultracentrifugation. , 1975, Analytical biochemistry.

[30]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.